Back

Disrupted Ca2+ homeostasis and immunodeficiency in patients with functional Inositol 1,4,5-trisphosphate receptor subtype 3 defects

Neumann, J.; van Nieuwenhove, E.; Terry, L. E.; Staels, F.; Knebel, T. R.; Welkenhuyzen, K.; Baker, M. R.; Gerbaux, M.; Willemsen, M.; Barber, J. S.; Serysheva, I. I.; De Waele, L.; Vermeulen, F.; Meyts, I.; Yule, D. I.; Bultynck, G.; Schrijvers, R.; Humblet-Baron, S.; Liston, A.

2021-06-08 allergy and immunology
10.1101/2021.05.29.21257775
Show abstract

Calcium signaling is essential for lymphocyte activation, with genetic disruptions resulting in severe immunodeficiency. The inositol 1,4,5-trisphosphate receptor (IP3R), formed from homo- or hetero-tetramers of the IP3R isoforms 1-3, amplifies lymphocyte signaling by releasing Ca2+ from ER stores into the cytosol following antigen-stimulation. While knockout of all 3 IP3R isoforms results in immunodeficiency in mice, the seeming redundancy of subunits was thought to explain the absence of IP3R mutation as a cause of human immunodeficiency. Here, we identify compound heterozygous variants in ITPR3 in two unrelated Caucasian patients presenting with combined immunodeficiency, in one case requiring hematopoietic stem cell transplantation. We observed disrupted Calcium homeostasis in patient-derived fibroblasts and immune cells, with abnormal proliferation and activation responses following B and T cell receptor stimulation. Reconstitution of IP3R knockout cell lines identified the variants as functional hypomorphs with reduced discrimination between homeostatic and induced states, validating a link between genotype and phenotype. These results demonstrate a functional linkage between defective ER Ca2+ channels and immunodeficiency, and identify IP3Rs as diagnostic targets for patients with specific inborn errors of immunity.

Matching journals

The top 8 journals account for 50% of the predicted probability mass.

1
Journal of Experimental Medicine
based on 10 papers
Top 0.1%
10.9%
2
eLife
based on 262 papers
Top 1%
10.0%
3
Nature Communications
based on 483 papers
Top 11%
7.4%
4
Journal of Clinical Investigation
based on 50 papers
Top 0.3%
5.2%
5
Journal of Clinical Immunology
based on 11 papers
Top 0.1%
4.4%
6
Nature Immunology
based on 14 papers
Top 0.3%
4.4%
7
The Journal of Immunology
based on 19 papers
Top 0.3%
4.4%
8
PLOS ONE
based on 1737 papers
Top 74%
4.4%
50% of probability mass above
9
Clinical Immunology
based on 12 papers
Top 0.3%
2.9%
10
JCI Insight
based on 63 papers
Top 2%
2.7%
11
Science Immunology
based on 15 papers
Top 0.3%
2.7%
12
Cell
based on 28 papers
Top 0.9%
2.4%
13
Communications Biology
based on 36 papers
Top 1.0%
2.3%
14
Cell Reports Medicine
based on 49 papers
Top 2%
2.3%
15
Cell Genomics
based on 34 papers
Top 1%
2.3%
16
Allergy
based on 13 papers
Top 0.8%
2.3%
17
The American Journal of Human Genetics
based on 77 papers
Top 5%
1.8%
18
Blood
based on 14 papers
Top 0.6%
1.5%
19
Scientific Reports
based on 701 papers
Top 73%
1.5%
20
Immunity
based on 11 papers
Top 0.6%
1.5%
21
Frontiers in Immunology
based on 140 papers
Top 6%
1.3%
22
Annals of the Rheumatic Diseases
based on 23 papers
Top 0.9%
1.3%
23
Brain
based on 69 papers
Top 6%
1.2%
24
Cell Reports
based on 25 papers
Top 1%
1.2%
25
Nature Medicine
based on 88 papers
Top 16%
0.8%
26
Clinical & Translational Immunology
based on 14 papers
Top 1%
0.7%
27
Proceedings of the National Academy of Sciences
based on 100 papers
Top 15%
0.7%
28
mSphere
based on 27 papers
Top 3%
0.7%
29
Journal of Allergy and Clinical Immunology
based on 15 papers
Top 2%
0.7%
30
Life Science Alliance
based on 11 papers
Top 0.5%
0.7%